|
Orthologous residues
|
|
ezrin (human): T567‑p, ezrin (mouse): T567‑p, ezrin (rat): T567‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
B lymphocyte-spleen [ezrin (human)], RAMOS (B lymphocyte) [ezrin (human)]
|
|
Cellular systems studied:
cell lines, primary cells
|
|
Species studied:
human, mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
anti-IgM
|
|
|
|
decrease
|
|
|